Skip to content

Study on the Effects of Alanyl-Glutamine Combined with ?-3 Fish Oil Fat Emulsion Parenteral Nutrition Support on Postoperative Inflammation and Nutritional Status in Patients with Gastroduodenal Perforation

Study on the Effects of Alanyl-Glutamine Combined with ?-3 Fish Oil Fat Emulsion Parenteral Nutrition Support on Postoperative Inflammation and Nutritional Status in Patients with Gastroduodenal Perforation

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2600122119
Enrollment
Unknown
Registered
2026-04-09
Start date
2026-04-20
Completion date
Unknown
Last updated
2026-04-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Gastroduodenal ulcer perforation

Interventions

Control Group 2:All-in-One Nutrition Solution + ?-3 Fish Oil Fat Emulsion
Control Group 2:All-in-One Nutrition Solution
Experimental group:All-in-One Nutrient Solution + L-Alanyl-L-Glutamine and ?-3 Fish Oil Emulsion

Sponsors

Yongchuan Hospital of Chongqing Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1.Age >=18 years; 2.Meeting the diagnostic criteria for gastroduodenal ulcer, presenting with a single perforation and confirmed by intraoperative findings; 3.Underwent laparoscopic repair of gastroduodenal ulcer perforation, with complete clinical data and reliable, undisputed laboratory indicators; 4.No history of other abdominal surgical procedures; 5.Mentally sound, with intact judgment, adequate comprehension and acceptance abilities, and normal verbal communication.

Exclusion criteria

Exclusion criteria: 1.Presence of other gastrointestinal diseases in addition to gastroduodenal ulcer; 2.Severe dysfunction of solid organs; 3.Coagulation disorders; 4.Severe disturbances of internal homeostasis; 5.Abnormal mental status or cognitive impairment; 6.Presence of severe diseases in other organ systems; 7.Concurrent gastrointestinal bleeding.

Design outcomes

Primary

MeasureTime frame
Serum albumin;Procalcitonin;Total protein;C-reactive protein;Neutrophil;Hemoglobin;Lymphocyte;White blood cell;

Secondary

MeasureTime frame
Abdominal abscess;Length of stay;Percutaneous repair and re-leakage;Weight changes;Lower extremity deep vein thrombosis;Intestinal obstruction;Lower limb venous thrombosis;Hospitalization costs;

Countries

China

Contacts

Public ContactXu Wei

Yongchuan Hospital of Chongqing Medical University

xw381153993@126.com+86 23 85381638

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Apr 17, 2026